Asian Spectator


The Times

.

Eisai Receives Approval for Parkinson's Disease Treatment Equfina in South Korea

  • Written by ACN Newswire - Press Releases

Eisai Receives Approval for Parkinson's Disease Treatment Equfina in South Korea

TOKYO, Jun 25, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that Eisai Korea Inc., Eisai's subsidiary in South Korea, has received marketing approval of Parkinson's disease treatment Equfina (safinamide mesilate, "safinamide") for the indication of treatment of idiopathic Parkinson's disease as adjunctive therapy with...

Magazine

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

Compressed Air Pipe and Fittings: What Every Australian Industrial Facility Needs to Know

Compressed air is the fourth utility of modern industry, right alongside electricity, gas, and water. Yet despite its critical role in powering everything from pneumatic tools to automated productio...

hacklink hack forum hacklink film izle hacklink IND RUMMYnon gamstop casinosnon gamstop casinos uknon gamstop casinoscasinos not on gamstopcasinos not on gamstopnon gamstop casinoonline gamblinguk casinosuk casinosStreamEastStreamEastcasibommeritkingcashnow.imweb.meimajbetcasibomcasibomcasinos not on gamstopcasino sites not on gamstopnon gamstop sitescasinos not on gamstopnon gamstop casinoszlibraryzlibraryzlibrarybetparkjojobetjojobetjojobetturkbetjojobetDeneme bonusumarsbahisjojobetjojobet